Table of Content

1. Preface
    1.1. Market Definition and Scope
    1.2. Market Segmentation
    1.3. Key Research Objectives
    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global In-Vitro Inflammatory Bowel Disease Diagnostics Market

4. Market Overview
    4.1. Introduction
        4.1.1. Segment Definition
    4.2. Overview
    4.3. Market Dynamics
        4.3.1. Drivers
        4.3.2. Restraints
        4.3.3. Opportunities
    4.4. Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Analysis and Forecasts, 2020 - 2034

5. Key Insights
    5.1. Key Product/Brand Analysis
    5.2. Technological Outlook
    5.3. Disease Prevalence and Incidence Rate of Colorectal Cancer in Europe
    5.4. Overview: National Screening Program Scenario
    5.5. Regulatory Scenario in Europe

6. Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Analysis and Forecasts, By Product
    6.1. Introduction & Definition
    6.2. Key Findings / Developments
    6.3. Market Value Forecast By Product, 2020 - 2034
        6.3.1. Assays/Biomarker
            6.3.1.1. Calprotectin
            6.3.1.2. Lactoferrin
            6.3.1.3. Bile Acids
            6.3.1.4. H. pylori SA
            6.3.1.5. Pancreatic Elastase
            6.3.1.6. Others
        6.3.2. Analyzers
    6.4. Market Attractiveness By Product

7. Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Analysis and Forecasts, By Testing Type
    7.1. Introduction & Definition
    7.2. Key Findings / Developments
    7.3. Market Value Forecast By Testing Type, 2020 - 2034
        7.3.1. Laboratory-based Testing
        7.3.2. Point-of-Care (POC) Testing
        7.3.3. Self-testing Kits
    7.4. Market Attractiveness By Testing Type

8. Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Analysis and Forecasts, By End-user
    8.1. Introduction & Definition
    8.2. Key Findings / Developments
    8.3. Market Value Forecast By End-user, 2020 - 2034
        8.3.1. Diagnostic Laboratories
        8.3.2. Hospitals
        8.3.3. Others (Homecare Testing & Research Institutes etc.)
    8.4. Market Attractiveness By End-user

9. Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Analysis and Forecasts, By Region
    9.1. Key Findings
    9.2. Market Value Forecast By Region
        9.2.1. North America
        9.2.2. Europe
        9.2.3. Asia Pacific
        9.2.4. Latin America
        9.2.5. Middle East & Africa
    9.3. Market Attractiveness By Country/Region

10. North America In-Vitro Inflammatory Bowel Disease Diagnostics Market Analysis and Forecast
    10.1. Introduction
        10.1.1. Key Findings
    10.2. Market Value Forecast By Product, 2020 - 2034
        10.2.1. Assays/Biomarker
            10.2.1.1. Calprotectin
            10.2.1.2. Lactoferrin
            10.2.1.3. Bile Acids
            10.2.1.4. H. pylori SA
            10.2.1.5. Pancreatic Elastase
            10.2.1.6. Others
        10.2.2. Analyzers
    10.3. Market Value Forecast By Testing Type, 2020 - 2034
        10.3.1. Laboratory-based Testing
        10.3.2. Point-of-Care (POC) Testing
        10.3.3. Self-testing Kits
    10.4. Market Value Forecast By End-user, 2020 - 2034
        10.4.1. Diagnostic Laboratories
        10.4.2. Hospitals
        10.4.3. Others (Homecare Testing & Research Institutes etc.)
    10.5. Market Value Forecast By Country, 2020 - 2034
        10.5.1. U.S.
        10.5.2. Canada
    10.6. Market Attractiveness Analysis
        10.6.1. By Product
        10.6.2. By Testing Type
        10.6.3. By End-user
        10.6.4. By Country

11. Europe In-Vitro Inflammatory Bowel Disease Diagnostics Market Analysis and Forecast
    11.1. Introduction
        11.1.1. Key Findings
    11.2. Market Value Forecast By Product, 2020 - 2034
        11.2.1. Assays/Biomarker
            11.2.1.1. Calprotectin
            11.2.1.2. Lactoferrin
            11.2.1.3. Bile Acids
            11.2.1.4. H. pylori SA
            11.2.1.5. Pancreatic Elastase
            11.2.1.6. Others
        11.2.2. Analyzers
    11.3. Market Value Forecast By Testing Type, 2020 - 2034
        11.3.1. Laboratory-based Testing
        11.3.2. Point-of-Care (POC) Testing
        11.3.3. Self-testing Kits
    11.4. Market Value Forecast By End-user, 2020 - 2034
        11.4.1. Diagnostic Laboratories
        11.4.2. Hospitals
        11.4.3. Others (Homecare Testing & Research Institutes etc.)
    11.5. Market Value Forecast By Country, 2020 - 2034
        11.5.1. Germany
        11.5.2. U.K.
        11.5.3. France
        11.5.4. Italy
        11.5.5. Spain
        11.5.6. Rest of Europe
    11.6. Market Attractiveness Analysis
        11.6.1. By Product
        11.6.2. By Testing Type
        11.6.3. By End-user
        11.6.4. By Country
12. Asia Pacific In-Vitro Inflammatory Bowel Disease Diagnostics Market Analysis and Forecast
    12.1. Introduction
        12.1.1. Key Findings
    12.2. Market Value Forecast By Product, 2020 - 2034
        12.2.1. Assays/Biomarker
            12.2.1.1. Calprotectin
            12.2.1.2. Lactoferrin
            12.2.1.3. Bile Acids
            12.2.1.4. H. pylori SA
            12.2.1.5. Pancreatic Elastase
            12.2.1.6. Others
        12.2.2. Analyzers
    12.3. Market Value Forecast By Testing Type, 2020 - 2034
        12.3.1. Laboratory-based Testing
        12.3.2. Point-of-Care (POC) Testing
        12.3.3. Self-testing Kits
    12.4. Market Value Forecast By End-user, 2020 - 2034
        12.4.1. Diagnostic Laboratories
        12.4.2. Hospitals
        12.4.3. Others (Homecare Testing & Research Institutes etc.)
    12.5. Market Value Forecast By Country, 2020 - 2034
        12.5.1. China
        12.5.2. India
        12.5.3. Japan
        12.5.4. Australia & New Zealand
        12.5.5. Rest of Asia Pacific
    12.6. Market Attractiveness Analysis
        12.6.1. By Product
        12.6.2. By Testing Type
        12.6.3. By End-user
        12.6.4. By Country
13. Latin America In-Vitro Inflammatory Bowel Disease Diagnostics Market Analysis and Forecast
    13.1. Introduction
        13.1.1. Key Findings
    13.2. Market Value Forecast By Product, 2020 - 2034
        13.2.1. Assays/Biomarker
            13.2.1.1. Calprotectin
            13.2.1.2. Lactoferrin
            13.2.1.3. Bile Acids
            13.2.1.4. H. pylori SA
            13.2.1.5. Pancreatic Elastase
            13.2.1.6. Others
        13.2.2. Analyzers
    13.3. Market Value Forecast By Testing Type, 2020 - 2034
        13.3.1. Laboratory-based Testing
        13.3.2. Point-of-Care (POC) Testing
        13.3.3. Self-testing Kits
    13.4. Market Value Forecast By End-user, 2020 - 2034
        13.4.1. Diagnostic Laboratories
        13.4.2. Hospitals
        13.4.3. Others (Homecare Testing & Research Institutes etc.)
    13.5. Market Value Forecast By Country, 2020 - 2034
        13.5.1. Brazil
        13.5.2. Mexico
        13.5.3. Rest of Latin America
    13.6. Market Attractiveness Analysis
        13.6.1. By Product
        13.6.2. By Testing Type
        13.6.3. By End-user
        13.6.4. By Country
14. Middle East & Africa In-Vitro Inflammatory Bowel Disease Diagnostics Market Analysis and Forecast
    14.1. Introduction
        14.1.1. Key Findings
    14.2. Market Value Forecast By Product, 2020 - 2034
        14.2.1. Assays/Biomarker
            14.2.1.1. Calprotectin
            14.2.1.2. Lactoferrin
            14.2.1.3. Bile Acids
            14.2.1.4. H. pylori SA
            14.2.1.5. Pancreatic Elastase
            14.2.1.6. Others
        14.2.2. Analyzers
    14.3. Market Value Forecast By Testing Type, 2020 - 2034
        14.3.1. Laboratory-based Testing
        14.3.2. Point-of-Care (POC) Testing
        14.3.3. Self-testing Kits
    14.4. Market Value Forecast By End-user, 2020 - 2034
        14.4.1. Diagnostic Laboratories
        14.4.2. Hospitals
        14.4.3. Others (Homecare Testing & Research Institutes etc.)
    14.5. Market Value Forecast By Country, 2020 - 2034
        14.5.1. GCC
        14.5.2. South Africa
        14.5.3. Rest of Middle East & Africa
    14.6. Market Attractiveness Analysis
        14.6.1. By Product
        14.6.2. By Testing Type
        14.6.3. By End-user
        14.6.4. By Country

15. Competition Landscape
    15.1. Global Dental Bearings Market : Company Share Analysis (2023)
    15.2. Company Profiles
        15.2.1. F. Hoffmann-La Roche AG
            15.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.2.1.2. Product Portfolio
            15.2.1.3. Financial Overview
            15.2.1.4. SWOT Analysis
            15.2.1.5. Strategic Overview
        15.2.2. Thermo Fisher Scientific Inc.
            15.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.2.2.2. Product Portfolio
            15.2.2.3. Financial Overview
            15.2.2.4. SWOT Analysis
            15.2.2.5. Strategic Overview
        15.2.3. Abbott Laboratories
            15.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.2.3.2. Product Portfolio
            15.2.3.3. Financial Overview
            15.2.3.4. SWOT Analysis
            15.2.3.5. Strategic Overview
        15.2.4. Sentinel Diagnostic
            15.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.2.4.2. Product Portfolio
            15.2.4.3. Financial Overview
            15.2.4.4. SWOT Analysis
            15.2.4.5. Strategic Overview
        15.2.5. BTNX Inc.
            15.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.2.5.2. Product Portfolio
            15.2.5.3. Financial Overview
            15.2.5.4. SWOT Analysis
            15.2.5.5. Strategic Overview
        15.2.6. Immundiagnostik AG
            15.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.2.6.2. Product Portfolio
            15.2.6.3. Financial Overview
            15.2.6.4. SWOT Analysis
            15.2.6.5. Strategic Overview
        15.2.7. Quest Diagnostics
            15.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.2.7.2. Product Portfolio
            15.2.7.3. Financial Overview
            15.2.7.4. SWOT Analysis
            15.2.7.5. Strategic Overview
        15.2.8. Sysmex Europe SE
            15.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.2.8.2. Product Portfolio
            15.2.8.3. Financial Overview
            15.2.8.4. SWOT Analysis
            15.2.8.5. Strategic Overview
        15.2.9. Diasorin S.p.A
            15.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.2.9.2. Product Portfolio
            15.2.9.3. Financial Overview
            15.2.9.4. SWOT Analysis
            15.2.9.5. Strategic Overview
        15.2.10. BioSystems S.A.
            15.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.2.10.2. Product Portfolio
            15.2.10.3. Financial Overview
            15.2.10.4. SWOT Analysis
            15.2.10.5. Strategic Overview
        15.2.11. QuidelOrtho Corporation
            15.2.11.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.2.11.2. Product Portfolio
            15.2.11.3. Financial Overview
            15.2.11.4. SWOT Analysis
            15.2.11.5. Strategic Overview
        15.2.12. Other Prominent Players
            15.2.12.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.2.12.2. Product Portfolio
            15.2.12.3. Financial Overview
            15.2.12.4. SWOT Analysis
            15.2.12.5. Strategic Overview



List of Figures

List of Figures

Figure 01: Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Forecast, 2020-2034

Figure 02: Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Value Share, by Product, 2023

Figure 03: Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Value Share, by Testing Type, 2023

Figure 04: Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Value Share, by End-user, 2023

Figure 05: Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Share Analysis, by Product, 2023 and 2034

Figure 06: Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Share Analysis, by Product, 2023

Figure 07: Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Share Analysis, by Product, 2034

Figure 08: Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Attractiveness Analysis, by Product, 2024-2034

Figure 09: Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn), by Assays/Biomarker, 2020?2034

Figure 10: Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Value Share Analysis, by Assays/Biomarker, 2024 and 2034

Figure 11: Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn), by Analyzers, 2020?2034

Figure 12: Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Value Share Analysis, by Analyzers, 2024 and 2034

Figure 13: Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Share Analysis, by Testing Type, 2023 and 2034

Figure 14: Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Share Analysis, by Testing Type, 2023

Figure 15: Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Share Analysis, by Testing Type, 2034

Figure 16: Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Attractiveness Analysis, by Testing Type, 2024-2034

Figure 17: Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn), by Clinical Testing Type, 2020?2034

Figure 18: Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Value Share Analysis, by Laboratory-based Testing, 2024 and 2034

Figure 19: Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn), by Point-of-Care (POC) Testing, 2020?2034

Figure 20: Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Value Share Analysis, by Point-of-Care (POC) Testing, 2024 and 2034

Figure 21: Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn), by Self-testing Kits, 2020?2034

Figure 22: Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Value Share Analysis, by Self-testing Kits, 2024 and 2034

Figure 23: Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Share Analysis, by End-user, 2023 and 2034

Figure 24: Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Share Analysis, by End-user, 2023

Figure 25: Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Share Analysis, by End-user, 2034

Figure 26: Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Attractiveness Analysis, by End-user, 2024-2034

Figure 27: Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn), by Hospitals, 2020?2034

Figure 28: Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Value Share Analysis, by Hospitals, 2024 and 2034

Figure 29: Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn), by Diagnostic Laboratories, 2020?2034

Figure 30: Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Value Share Analysis, by Diagnostic Laboratories, 2024 and 2034

Figure 31: Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn), by Others, 2020?2034

Figure 32: Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Value Share Analysis, by Others, 2024 and 2034

Figure 33: Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Value Share Analysis, by Region, 2023 and 2034

Figure 34: Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Share Analysis, by Region, 2023

Figure 35: Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Share Analysis, by Region, 2034

Figure 36: Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Attractiveness Analysis, by Region, 2024-2034

Figure 37: North America In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034

Figure 38: North America In-Vitro Inflammatory Bowel Disease Diagnostics Market Value Share Analysis, by Country, 2023 and 2034

Figure 39: North America In-Vitro Inflammatory Bowel Disease Diagnostics Market Attractiveness Analysis, by Country, 2024-2034

Figure 40: North America In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Share Analysis, by Product, 2023 and 2034

Figure 41: North America In-Vitro Inflammatory Bowel Disease Diagnostics Market Attractiveness Analysis, by Product, 2024-2034

Figure 42: North America In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Share Analysis, by Testing Type, 2023 and 2034

Figure 43: North America In-Vitro Inflammatory Bowel Disease Diagnostics Market Attractiveness Analysis, by Testing Type, 2024-2034

Figure 44: North America In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Share Analysis, by End-user, 2023 and 2034

Figure 45: North America In-Vitro Inflammatory Bowel Disease Diagnostics Market Attractiveness Analysis, by End-user, 2024-2034

Figure 46: Europe In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034

Figure 47: Europe In-Vitro Inflammatory Bowel Disease Diagnostics Market Value Share Analysis, by Country/Sub-region, 2023 and 2034

Figure 48: Europe In-Vitro Inflammatory Bowel Disease Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2024-2034

Figure 49: Europe In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Share Analysis, by Product, 2023 and 2034

Figure 50: Europe In-Vitro Inflammatory Bowel Disease Diagnostics Market Attractiveness Analysis, by Product, 2024-2034

Figure 51: Europe In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Share Analysis, by Testing Type, 2023 and 2034

Figure 52: Europe In-Vitro Inflammatory Bowel Disease Diagnostics Market Attractiveness Analysis, by Testing Type, 2024-2034

Figure 53: Europe In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Share Analysis, by End-user, 2023 and 2034

Figure 54: Europe In-Vitro Inflammatory Bowel Disease Diagnostics Market Attractiveness Analysis, by End-user, 2024-2034

Figure 55: Asia Pacific In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034

Figure 56: Asia Pacific In-Vitro Inflammatory Bowel Disease Diagnostics Market Value Share Analysis, by Country/Sub-region, 2023 and 2034

Figure 57: Asia Pacific In-Vitro Inflammatory Bowel Disease Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2024-2034

Figure 58: Asia Pacific In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Share Analysis, by Product, 2023 and 2034

Figure 59: Asia Pacific In-Vitro Inflammatory Bowel Disease Diagnostics Market Attractiveness Analysis, by Product, 2024-2034

Figure 60: Asia Pacific In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Share Analysis, by Testing Type, 2023 and 2034

Figure 61: Asia Pacific In-Vitro Inflammatory Bowel Disease Diagnostics Market Attractiveness Analysis, by Testing Type, 2024-2034

Figure 62: Asia Pacific In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Share Analysis, by End-user, 2023 and 2034

Figure 63: Asia Pacific In-Vitro Inflammatory Bowel Disease Diagnostics Market Attractiveness Analysis, by End-user, 2024-2034

Figure 64: Latin America In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034

Figure 65: Latin America In-Vitro Inflammatory Bowel Disease Diagnostics Market Value Share Analysis, by Country/Sub-region, 2023 and 2034

Figure 66: Latin America In-Vitro Inflammatory Bowel Disease Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2024-2034

Figure 67: Latin America In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Share Analysis, by Product, 2023 and 2034

Figure 68: Latin America In-Vitro Inflammatory Bowel Disease Diagnostics Market Attractiveness Analysis, by Product, 2024-2034

Figure 69: Latin America In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Share Analysis, by Testing Type, 2023 and 2034

Figure 70: Latin America In-Vitro Inflammatory Bowel Disease Diagnostics Market Attractiveness Analysis, by Testing Type, 2024-2034

Figure 71: Latin America In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Share Analysis, by End-user, 2023 and 2034

Figure 72: Latin America In-Vitro Inflammatory Bowel Disease Diagnostics Market Attractiveness Analysis, by End-user, 2024-2034

Figure 73: Middle East & Africa In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034

Figure 74: Middle East & Africa In-Vitro Inflammatory Bowel Disease Diagnostics Market Value Share Analysis, by Country/Sub-region, 2023 and 2034

Figure 75: Middle East & Africa In-Vitro Inflammatory Bowel Disease Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2024-2034

Figure 76: Middle East & Africa In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Share Analysis, by Product, 2023 and 2034

Figure 77: Middle East & Africa In-Vitro Inflammatory Bowel Disease Diagnostics Market Attractiveness Analysis, by Product, 2024-2034

Figure 78: Middle East & Africa In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Share Analysis, by Testing Type, 2023 and 2034

Figure 79: Middle East & Africa In-Vitro Inflammatory Bowel Disease Diagnostics Market Attractiveness Analysis, by Testing Type, 2024-2034

Figure 80: Middle East & Africa In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Share Analysis, by End-user, 2023 and 2034

Figure 81: Middle East & Africa In-Vitro Inflammatory Bowel Disease Diagnostics Market Attractiveness Analysis, by End-user, 2024-2034

List of Tables

List of Tables

Table 01: Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Forecast, by Product, 2020-2034

Table 02: Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Forecast, by Assays/Biomarker, 2020-2034

Table 03: Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Forecast, by Testing Type, 2020-2034

Table 04: Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Forecast, by End-user, 2020-2034

Table 05: Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Forecast, by Region, 2020-2034

Table 06: North America In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Forecast, by Country, 2020-2034

Table 07: North America In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Forecast, by Product, 2020-2034

Table 08: North America In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Forecast, by Product, 2020-2034

Table 09: North America In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Forecast, by Testing Type, 2020-2034

Table 10: North America In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Forecast, by End-user, 2020-2034

Table 11: Europe In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Forecast, by Country/Sub-region, 2020-2034

Table 12: Europe In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Forecast, by Product, 2020-2034

Table 13: Europe In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Forecast, by Product, 2020-2034

Table 14: Europe In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Forecast, by Testing Type, 2020-2034

Table 15: Europe In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Forecast, by End-user, 2020-2034

Table 16: Asia Pacific In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Forecast, by Country/Sub-region, 2020-2034

Table 17: Asia Pacific In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Forecast, by Product, 2020-2034

Table 18: Asia Pacific In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Forecast, by Product, 2020-2034

Table 19: Asia Pacific In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Forecast, by Testing Type, 2020-2034

Table 20: Asia Pacific In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Forecast, by End-user, 2020-2034

Table 21: Latin America In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Forecast, by Country/Sub-region, 2020-2034

Table 22: Latin America In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Forecast, by Product, 2020-2034

Table 23: Latin America In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Forecast, by Product, 2020-2034

Table 24: Latin America In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Forecast, by Testing Type, 2020-2034

Table 25: Latin America In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Forecast, by End-user, 2020-2034

Table 26: Middle East & Africa In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Forecast, by Country/Sub-region, 2020-2034

Table 27: Middle East & Africa In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Forecast, by Product, 2020-2034

Table 28: Middle East & Africa In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Forecast, by Product, 2020-2034

Table 29: Middle East & Africa In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Forecast, by Testing Type, 2020-2034

Table 30: Middle East & Africa In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Forecast, by End-user, 2020-2034